CORTICOBASAL DEGENERATION

Clinical trials for CORTICOBASAL DEGENERATION explained in plain language.

Never miss a new study

Get alerted when new CORTICOBASAL DEGENERATION trials appear

Sign up with your email to follow new studies for CORTICOBASAL DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 5 Not yet finished but already full! 3 Completed 1 Terminated 1

Experimental drug aims to curb disinhibition in dementia patients

Symptom relief Terminated

This study tested a drug called AVP-786 to see if it could safely reduce disinhibition—impulsive or inappropriate behavior—in people with neurodegenerative disorders like Alzheimer's or frontotemporal dementia. The trial planned to include many participants but was terminated ear…

Matched conditions: CORTICOBASAL DEGENERATION

Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 12:32 UTC

CORTICOBASAL DEGENERATION

Get alerted when new CORTICOBASAL DEGENERATION trials appear

Experimental drug aims to curb disinhibition in dementia patients